Drug Discovery in Cancer Epigenetics

Anno: 2015
Rilegatura: Hardback
Pagine: 498 p.
Testo in English
Dimensioni: 235 x 191 mm
Peso: 1200 gr.
  • EAN: 9780128022085
pagabile con 18App pagabile con Carta del Docente

Articolo acquistabile con 18App e Carta del Docente

€ 125,39

€ 136,29

Risparmi € 10,90 (8%)

Venduto e spedito da IBS

125 punti Premium

Disponibile in 4/5 settimane

Quantità:
Descrizione
Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.